Innovation | Ophthalmology Innovation Source

CXLO

Presenter: Roy Rubinfeld, MD Dr. Rubinfeld was the first Washington area ophthalmologist to become involved in the care of laser vision correction patients in 1991. He has performed tens of thousands of LASIK and many PRK and other vision correction procedures. View Full Profile

Refractec – The Tale of an Evolution in Need of a Revolution

Refractec was really a revolution at the time in terms of reshaping the cornea, but was in need of an evolution of how we think of the cornea. This technology if introduced today would have had an even more robust life. Presenter: Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which…

Innovation Cycle Overview & Financing Environment Update

Presenter: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. View Full Profile

Review of the Ophthalmology Innovation Cycle – Panel Discussion

Join William J. Link, PhD as he leads a panel discussion on the risks associated with the innovation cycle and the lessons learned. Moderators: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986. View…

Innovation, Industry and Consultants – Good for Patients

Polio crippled President Franklin D. Roosevelt, and it infected and often paralyzed thousands of other Americans—58,000 in 1952 alone. Many historians consider the eradication of polio in the United States the greatest medical breakthrough of the 20th century. As recently as 1988, polio infected 350,000 individuals worldwide. In 2001, the World Health Organization documented only…

OIS@AAO 2013 Executive Summary

More than 800 attendees participated in the fifth annual Ophthalmology Innovation Summit, held November 14, 2013, just prior to the annual meeting of the American Academy of Ophthalmology in New Orleans, LA. The full-day focus on innovation in ophthalmology included private pharmaceutical and device company showcases and stimulating discussions with venture capitalists, specialists in public…

EU Commercialization Strategies

Summit Co-Chair and Managing Director for InterWest Partners, Gilbert Kliman MD, captures the audience’s thoughts on commercialization strategies in Europe through a series of live polling questions. Also gaining the expert opinions of panelists, Laurent Attias, David Muller, David E.I. Pyott, Jim Mazzo and Andy Corley, Gil compares the who, what and where questions that…

2013 Ophthalmic Market – “Year in Review”

Emmett T. Cunningham Jr. MD PhD MPH, Partner at Clarus Ventures and Summit Chairman, delivers an overview of some ophthalmic highlights from 2013. Sharing key accomplishments from many device and pharma companies, Emmett continues to expand on the present landscape with promising data to show that the ophthalmology market is stable despite the decrease in…

Bill Link Dives into his Perspective of Venture Overseas

William J. Link PhD, Managing Director for Versant Ventures, gives the audience at the 5th Annual Ophthalmology Innovation Summit a look into the returns on the venture investing side and the comparison between the US and Europe. Utilizing specific data and numbers, Bill continues to share his personal biases as an American in the US…

Jonathan Norris Predicts a Positive Cycle in the Ophthalmic Private Market

Private Funding and Exit Trends Jonathan Norris, Managing Director for SVB Capital, takes the stage to share the positive sentiments on the private markets. Highlighting in detail venture healthcare funds, Series A and M&A, Jonathan predicts stability in fundraising dollars, while investment dollars in the companies will begin to decline, expanding on the important role…

iCo Therapeutics Sidesteps VEGF in Diabetic Macular Edema

iCo Therapeutics – Andrew Rae, President & CEO for iCo Therapeutics, shares the company’s focus on diabetic macular edema and their 187 patient study, which is fully enrolled in the U.S. Viewing an opportunity to better serve this population, ICO Therapeutics talks about their products that provide improved outcomes for patients not responding or only…

Physician Entrepreneurship in Ophthalmology

Striving to reach the aspiring entrepreneurs in the crowd at the 5th Annual Ophthalmology Innovation Summit @ AAO in New Orleans, Dick Lindstrom leads an experienced panel of entrepreneurs and tech developers through a series of focused questions. Sharing their highly coveted successes and failures, these panelists cover all aspects of entrepreneurship from focusing in…